Global DDF Summit – Drug Delivery & Formulation
May 18-20, 2026
Berlin, Germany
https://ddfevent.com/live/en/page/home
Subscribe to our press distribution list to receive the latest news about AMW.
May 18-20, 2026
Berlin, Germany
https://ddfevent.com/live/en/page/home
June 22-25, 2026
San Diego, USA
https://convention.bio.org/
July 6-9, 2026
Lisbon, Portugal
https://www.controlledreleasesociety.org/events/crs-2026-annual-meeting-exposition
July 8-10, 2026
Bangkok, Thailand
https://www.cphi.com/sea/en/attend/attend/why-attend.html
October 6-8, 2026
Milan, Italy
https://www.cphi.com/europe/en/exhibit/book-your-stand-milan.html
October 29-30, 2026
Boston, USA
https://poddconference.com/
November 9-11, 2026
Cologne, Germany
https://informaconnect.com/bioeurope/
May 22-24, 2025
Vienna, Austria
September 29 – October 1, 2025
Berlin, Germany
https://ipls.online/events/
October 28-30, 2025
Frankfurt, Germany
https://www.cphi.com/europe/en/home.html
February 5-6, 2026
London, UK
https://pharma-synergy-conference.com/pharmasynergy-2026/
March 2-3, 2026
Lisbon, Portugal
https://www.raucon.com/euro-plx/euro-p-l-x-90
March 23-25, 2026
Lisbon, Portugal
https://informaconnect.com/bioeurope-spring/
March 23-26, 2026
New York City, USA
https://dcatweek.org/
March 23-26, 2026
Prague, Czech Republic
https://worldmeeting.org/
March 24-27, 2026
Munich, Germany
https://analytica.de/de/muenchen/
May 3-7, 2026
Denver, USA
https://www.arvo.org/annual-meeting
Warngau, Germany, Chenôve, France, May 27, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, and AdhexPharma SAS, an independent pharmaceutical company specializing in the development and manufacturing of patches and oral films, today announced the successful completion of the transfer of transdermal delivery systems (TDS) under the companies’ strategic […]
read moreWarngau, Germany, May 13, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today reported financial results for the year ended December 31, 2024. AMW posted another consolidated record revenue for 2024 of EUR 38.2 million, an increase of 30% compared to the previous year (2023: EUR 29.4 million). The […]
read moreWarngau, February 25, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the launch of a research and development project to optimize formulation development using artificial intelligence (AI). The working group of Prof. Dr. Olivia Merkel, Chair of Drug Delivery at the Department of Pharmacy at Ludwig-Maximilians-Universität (LMU) […]
read moreWarngau, Germany, July 1, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the appointment of Prof. Miriam Breunig, Senior Academic Councillor at the University of Regensburg’s Department of Pharmaceutical Technology, and Prof. Karsten Mäder, Professor of Pharmaceutics at Martin Luther University Halle-Wittenberg, as members to AMW’s Scientific […]
read moreWarngau, June 3, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today reported financial results for the year ended December 31, 2023. AMW posted a 2023 consolidated record revenue of EUR 29.4 million and achieved operating profitability for the second consecutive year. In addition, the Company reported a partial […]
read moreYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information